APA (7th ed.) Citation

Chapman, S. R., Fitzpatrick, R. W., & Aladul, M. I. (2017). Has cost inhibited the uptake of more potent statins in England? Pharmacoepidemiology & Drug Safety, 26(8), 984. https://doi.org/10.1002/pds.4231

Chicago Style (17th ed.) Citation

Chapman, Stephen R., Raymond W. Fitzpatrick, and Mohammed I. Aladul. "Has Cost Inhibited the Uptake of More Potent Statins in England?" Pharmacoepidemiology & Drug Safety 26, no. 8 (2017): 984. https://doi.org/10.1002/pds.4231.

MLA (9th ed.) Citation

Chapman, Stephen R., et al. "Has Cost Inhibited the Uptake of More Potent Statins in England?" Pharmacoepidemiology & Drug Safety, vol. 26, no. 8, 2017, p. 984, https://doi.org/10.1002/pds.4231.